Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in cN0 Breast Cancer: Impact of HER2-Positive Status on Survival

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Research on Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Therapy in <scp>cN1</scp> Breast Cancer Patients2026
2. 2Abstract PS2-05-12: Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Clinically Node-Negative Early Breast Cancer: Feasibility and Safety in Triple-Negative and HER2-Positive Breast Cancer Subtypes2026
3. 3The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes2024 · 3 citations
4. 4101P Correlation of radiological and pathologic lymph nodes status after neoadjuvant treatment of early HER2-positive breast cancer2024
5. 5Prediction of the number of positive axillary lymph nodes according to sentinel lymph node involvement and biological subtypes in patients receiving neoadjuvant chemotherapy2024 · 2 citations